본문 바로가기

company

Greeting

Health is the greatest wealth
NKMAX

NKMAX was founded on the belief that ‘Health is the greatest wealth’. The company and its employees are committed to both improving quality of life and saving lives, whether by developing new immunotherapies, providing novel diagnostic tests, or providing the research community with research reagents that are crucial for life science advancements.

NKMAX has developed the world ‘s first and only commercially available NK Cell activity test. In addition, NKMAX provides high quality health supplements to help strengthen the immune system.

NKMAX recently expanded its business to the cell therapy market by focusing on the immune system and developing an immunotherapy called SuperNK, which overcomes the limitations of existing NK cell therapy. NKMAX aims to provide the safest and most effective immunotherapy.

NKMAX harnesses the power of the body’s immune system through the development of a unique Natural Killer (NK) cell immunotherapy. NKMAX strives to fulfill its mission and vision to become a global leader in the healthcare industry.

Thank you.

 

Global NK cell Leader

개요도
Natural Killer Cells
  • Immunotherapy - Immune-based Treatment
  • NK Vue Kit: NK Cell Activity Diagnostic Kit - Immune function Diagnosis
  • NK365: Health Supplements - Immune system care

Leadership

NKMAX Brings happiness through health.

Chairman and CEO

Sang Woo Park

  • NKMAX Chairman
  • ATGen CEO (2002~2019)
  • Doyouweb (2000~2002)
  • Analyst at Samsung Securities (1996~2000)
  • B.A. Economics, Korea University
  • Chief Medical Officer

    Paul. Y Song SVP, NKMAX America

    • Chief Medical Officer, Cynvenio Biosystems Inc.
    • Physician, Cedars-Sinai Medical Center
    • SVP, BERG Health
    • Physician, John Wayne Cancer Institute
    • Radiation Oncology, University of Chicago Medical Center
    • M.D. George Washington University School of Medicine
    • B.A. with Honors, Biological Sciences, University of Chicago
  • Chief Operation Officer

    Yong Hwan Cho Vice President

    • ATGen COO (2015~2019)
    • Ministry of Government Administration and Home Affairs (2013~2015)
    • Executive office of the President at the Blue House (2010~2013)
    • Ministry of Health and Welfare (2008~2010)
    • National Assembly Secretariat (2002~2008)
    • B.S. Business Administration, Korea University
  • Chief Technical Officer

    Stephen Chen SVP, NKMAX America / Director, QA

    • Director of QA/QC, ARMO Biosciences
    • Director of QA, KITE Pharma Inc.,
    • Director of Quality, Channel Technologies Group
    • Baxter International
    • MBA. University of Southern California
    • B.S. Cell Biology, University of California San Diego
  • Chief Technical Officer

    Yong Man Kim Executive Director

    • Pharmicell Inc. (2005~2017)
    • Wonkwang University School of Medicine (2003~2005)
    • National Institute of Health (NIH) (2000~2003)
    • Korean Research Institute of Bioscience & Biotechnology (KRIBB) (1997~2000)
    • Ph.D. Biology, Chungnam National University
  • Chief Scientific Officer

    Amber Kaplan SVP

    • Venture Partner, WEBridge Ventures
    • Investment Analyst, AI List (Venture capital)
    • Scientist, ADRx, Inc.
    • Post-Doc. University of California, Los Angeles
    • Ph.D. Immunology, Cedars-Sinai Medical Center
    • B.A. Biology, University of California, Santa Barbara

Move to Top